Company / Revenue per Share
Veracyte, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$6.65
FY2025
5-year range
$3.77 / $6.65
FY2021-FY2025
Trend
+9.3%
vs FY2024
Sector context
#121 of 147
Health Care
What the data says
Veracyte, Inc.'s revenue per share of $6.65 is lower than 82% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 5 consecutive years, from $2.37 in FY2020 to $6.65 in FY2025.
Based on SEC 10-K filings.
6.65 in FY2025 with a 5-year CAGR of +22.9%.
Improved from $5.02 to $6.65 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +16.8%
- 5-Year CAGR
- +22.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 147This company $6.65 Sector average $127.83
▼
-94.8% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s revenue per share has grown for 5 consecutive years.
- In FY2025, revenue per share increased 9.3% year-over-year.
- Ranks #121 out of 147 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.65 | +9.3% |
| FY2024 | $6.08 | +21.3% |
| FY2023 | $5.02 | +20.3% |
| FY2022 | $4.17 | +10.5% |
| FY2021 | $3.77 | +59.3% |
| FY2020 | $2.37 | -19.6% |
| FY2019 | $2.95 | +8.1% |
| FY2018 | $2.73 | +27.9% |
| FY2017 | $2.13 | -9.3% |
| FY2016 | $2.35 | +7.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026